One blood test. A signal shared by many cancers.
Galleri by GRAIL looks for DNA-methylation patterns shed by cancer cells — a screening tool we offer with clear, honest guidance.
Quick answer
Galleri by GRAIL is a multi-cancer early-detection blood test offered at Next Level in Scottsdale. It looks for DNA-methylation patterns present in cancer cells across many cancer types. It is a screening tool — not a definitive diagnosis — and our physicians explain its real strengths and limits so you can decide if it fits your prevention plan.
| What it is | Multi-cancer early-detection blood test |
|---|---|
| How it works | Detects DNA-methylation patterns from cancer |
| Important | A screening test, not a diagnosis |
| Accuracy | ~51% overall sensitivity — we explain honestly |
| Location | Scottsdale, AZ · by appointment |
A powerful tool — used responsibly
Galleri is a DNA-methylation blood test that looks for specific patterns present in cancer cells. From a single blood draw it can screen for a signal shared by many cancer types — several of which have no routine screening test today.
We believe in honesty about what it can and can’t do. Galleri is roughly 51% accurate overall at finding cancer when it’s present — valuable as part of a broader prevention strategy, but not a replacement for standard screening. We help you understand exactly where it fits.
- Screens for many cancers from one blood draw
- Includes cancers with no routine screening
- A complement to — not a replacement for — standard tests
- Explained honestly, with realistic expectations
Multi-cancer screening, in context
Many Cancers, One Test
Screens for a signal shared across many cancer types from a single draw.
Methylation Science
Detects DNA-methylation patterns characteristic of cancer cells.
Honest Guidance
We explain its ~51% overall sensitivity and what it does and doesn’t catch.
Part of a Plan
Used alongside standard screening, imaging and your risk profile.
Clear Next Steps
If a signal is found, we guide diagnostic follow-up and coordination.
Proactive Prevention
One more layer in a comprehensive, early-detection strategy.
Galleri by GRAIL FAQs
Galleri is a DNA-methylation test that looks for patterns present in cancer cells. It is about 51% accurate overall at detecting cancer when present — stronger for some cancer types than others. It is a screening tool, not a definitive diagnosis, and we explain its limits clearly.
No. Galleri complements standard screening (like mammography and colonoscopy) and can flag cancers with no routine test — but it does not replace them. We use it as one layer of a complete prevention plan.
We guide appropriate diagnostic follow-up and coordinate with specialists. A signal is a prompt to investigate, not a diagnosis — and we walk with you through every step.
Next Level Concierge Care is independent; outbound links are provided for verification and are not endorsements.
A smarter layer of early detection
Ask whether Galleri makes sense as part of your prevention plan.